Last updated: December 7, 2022
Sponsor: Tan Tock Seng Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stroke
Cerebral Ischemia
Treatment
N/AClinical Study ID
NCT05642299
2021/00715
Ages 50-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- first ever stroke prior to clinical trial
- Fugl-Meyer Assessment scale of upper extremity impairment of 11-45 out of a maximumscore of 66
- ability to give own consent
- ability to pay attention and maintain supported sitting for 1.5 hours continuously
- able to comprehend and follow commands
- fulfils BCI resting brain states on initial screening
- unilateral upper limb impairment
Exclusion
Exclusion Criteria:
- recurrent stroke
- inability to follow command and sit upright for 1.5 hours
- hemi-spatial neglect
- spasticity assessed by Modified Ashworth Scale more than 2/4
- History of Epilepsy
- Fixed contracture / deformity of finger joints
- upper limb pain impeding movements with visual analogy scale > 4/10
- Severe aphasia or cognitive impairment despite visual aids
- other conditions ensuing upper limb weakness
- poor skin conditions
- skull defect that might affect EEG or NIRS reading
- allergy to electrodes or adhesive gel
- significant vision and hearing impairment affecting participation
- Pregnant women
Study Design
Total Participants: 10
Study Start date:
December 01, 2022
Estimated Completion Date:
December 14, 2023
Study Description
Connect with a study center
Tan Tock Seng Hospital Rehabilitation Centre
Singapore, 569766
SingaporeActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.